416
Views
5
CrossRef citations to date
0
Altmetric
Poison Centres

A 13-year review of lisinopril ingestions in children less than 6 years of age

&
Pages 864-870 | Received 29 Apr 2013, Accepted 09 Aug 2013, Published online: 22 Aug 2013

References

  • Capes KF. Angiotensin converting enzyme inhibitors. In: Viccellio P, ed. Emergency Toxicology. 2nd ed. Philadelphia: Lippincott-Raven; 1998:681–85.
  • Zestril (lisinopril) Package insert. Available at: http://www1.astrazeneca-us.com/pi/zestrillpv.pdf [Accessed on April 9, 2013].
  • Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE. Goldfrank's Toxicologic Emergencies. 8th ed. New York: McGraw Hill, 2006:951–953.
  • Leiken, JB, Paloucek FP eds. Poison and Toxicology Compendium with Symptoms Index. Hudson Ohio: Lexi-Corp Inc; 1998:356–57.
  • Taketomo CK, Hodding JH, Kraus DM. Pediatric and Neonatal Dosage Handbook. 18th ed. Hudson, Ohio: Lexicomp; 2011:904.
  • Hogg RJ, Delucchi A, Sakihara G, Wells TG, Tenney F, Batisky DL, et al. A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatr Nephrol 2007; 22: 695–701.
  • Bronstein AC, Spyker DA, Cantilena LR, Rumack BH, Dart RC. 2011 annual report of the American association of poison control centers’ national poison data system (NPDS): 29th annual report. Clin Toxicol 2012; 50:911–1164.
  • Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Drab A, et al. 1999 Annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med 1999; 18:517–574.
  • Alderman CP. Adverse effects of the angiotensin-converting enzyme inhibitors. Ann Pharmacother 1996; 30:55–61.
  • Trilli LE, Johnson KA. Lisinopril overdose and management with intravenous angiotensin II. Ann Pharmacother 1994; 28:1165–1168.
  • Dawson AH, Harvey D, Smith AJ, Taylor M, Whyte IM, Johson CI, et al. Lisinopril overdose. Lancet 1990; 335:487–488.
  • Hogue-Murray K, Horowitz R, Dart RC. Outcome of ACE inhibitor ingestion in children under the age of six years. J Toxicol Clin Toxicol 1995; 33:509–510.
  • Balit CR, Gilmore SP, Isbister GK. Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists. J Paediatr Child Health 2007; 43:686–688.
  • Poison Control Center Activity Report. CPCS 2012. (internal document).
  • Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Heard SE. 2007 Annual report of the American association of poison control centers’ national poison data system (NPDS): 25th annual report. Clin Toxicol 2008; 46:927–1057.
  • American heart association emergency cardiovascular care committee. 2005 American heart association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC). Circulation 2005; 112:IV–167.
  • Custer J, Rau R, eds. The Harriet Lane Handbook: a Manual for Pediatric House Officers. 18th ed. Philadelphia: Mosby Elselvier; 2009.
  • Forrester MB. Pediatric lisinopril ingestions reported to Texas poison control centers. Hum Exp Toxicol 2007; 26: 83–89.
  • Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE. Goldfrank's Toxicologic Emergencies. 8th ed. New York: McGraw Hill; 2006:924–941.
  • Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE. Goldfrank's Toxicologic Emergencies. 8th ed. New York: McGraw Hill; 2006:911–923.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.